Advertisement
Advertisement
U.S. Markets close in 44 mins
Advertisement
Advertisement
Advertisement
Advertisement

Asensus Surgical, Inc. (ASXC)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.6700+0.0100 (+1.52%)
As of 03:16PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.6600
Open0.6600
Bid0.6550 x 800
Ask0.6649 x 1800
Day's Range0.6515 - 0.7200
52 Week Range0.3500 - 2.4200
Volume2,382,021
Avg. Volume2,603,887
Market Cap166.856M
Beta (5Y Monthly)1.60
PE Ratio (TTM)N/A
EPS (TTM)-0.3110
Earnings DateMar 09, 2022 - Mar 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Asensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2022

    RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the second quarter 2022. Recent Highlights Over 670 procedures were performed globally during the quarter, representing growth of 34% over the prior year quarter, including 77% growth in

  • GlobeNewswire

    Asensus Surgical Announces Sale of Senhance Robotic System

    Senhance System to be placed at hospital in the Commonwealth of Independent States Senhance Surgical System Performance-Guided Surgery™ Leveraging the Performance-Guided Surgery™ framework, the Senhance Surgical System advances clinical intelligence by providing surgeons with augmented intelligence and digital tools to perform consistently superior surgery. RESEARCH TRIANGLE PARK, N.C., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that

  • GlobeNewswire

    Asensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 8, 2022

    RESEARCH TRIANGLE PARK, N.C., July 26, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2022 second quarter financial and operating results after the market closes on Monday, August 8, 2022. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day.

Advertisement
Advertisement